# OnCo record antwerp-university-hospital (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/antwerp-university-hospital/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "antwerp-university-hospital" ;
  schema:name "Antwerp University Hospital (UZA)"@en ;
  schema:alternateName "UZA"@en, "Universitair Ziekenhuis Antwerpen"@en ;
  schema:description "Belgium's Antwerp university hospital, where Jan Vermorken led EXTREME, the trial that made cetuximab plus chemotherapy the first-line standard for recurrent head and neck cancer for a decade."@en ;
  schema:url <https://onco.cc/institutions/antwerp-university-hospital/>, <https://www.uza.be> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://www.uza.be> ;
  schema:addressCountry "BE" ;
  schema:addressLocality "Edegem" ;
  schema:latitude "51.155"^^xsd:decimal ;
  schema:longitude "4.421"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:people <https://onco.cc/people/jan-vermorken/> .